Funded Tech Companies

Initial Therapeutics

Researching who backed Initial Therapeutics? Apple Tree Partners joined the equity holders in this biopharmaceutical company.

Company Overview

Company Name
Initial Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
285 east grand avenue south
San Francisco, CA 94080
USA
Email Address

Company Background Information

Overview
Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages. Initial's approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.
Profile
Initial Therapeutics LinkedIn Company Profile
Social Media
Initial Therapeutics Company Twitter Account
Company News
Initial Therapeutics News
Facebook
Initial Therapeutics on Facebook
YouTube
Initial Therapeutics on YouTube
Last Transaction
5/1/2023

Financing History

Date
Type
Amount
Venture Equity
$75,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Spiros Liras
  Spiros Liras LinkedIn Profile  Spiros Liras Twitter Account  Spiros Liras News  Spiros Liras on Facebook
Co-Founder
Brian Paegel
  Brian Paegel LinkedIn Profile  Brian Paegel Twitter Account  Brian Paegel News  Brian Paegel on Facebook
Co-Founder
Kevan Shokat
  Kevan Shokat LinkedIn Profile  Kevan Shokat Twitter Account  Kevan Shokat News  Kevan Shokat on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Initial State | Initiate Systems

 

Share this article

 


About Our VC Funding Database

The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary